New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Il rapporto

Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo

39 report e oltre

Aggiornato quotidianamente con le ultime intelligence di mercato
Headquarters
Collegium Pharmaceutical

Collegium Pharmaceutical Plans Headquarters Move to Downtown Boston

Collegium Pharmaceutical plans to move its corporate headquarters from Stoughton to One Lincoln in downtown Boston during the first quarter of 2027.

SalesTools Research
Jul 20, 2026
2 min read
Pharmaceuticals
BioPharmaceuticals Next

BioPharmaceuticals Next Secures $1.6B Series E to Lead Pharmaceuticals Innovation

BioPharmaceuticals Next raises $1.6B in Series E funding at $24.3B valuation to advance 12 drug candidates through clinical trials, scale gene therapy manufacturing, and expand personalized medicine programs.

Editorial Team
Sep 20, 2025
0 min read•$1.6B
Biotechnology - Neuropsychiatry
Seaport Therapeutics

Seaport Therapeutics Raises $225 Million in Series B - October 21, 2024

Seaport Therapeutics announced $225 Million in Series B funding at a Undisclosed valuation. Seaport Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for neuropsychiatric disorders using prodrug technology ...

James Rodriguez
Oct 26, 2025
0 min read•$225 Million
Pharmaceuticals
Shire

Shire raises $50B Public at $55B valuation

Shire raises $50B in Public at $55B valuation. Biopharmaceutical company...

Editorial Team
Jan 1, 2024
0 min read•$50B
Pharmaceutical
Biogen

Biogen raises $40B Public at $45B valuation

Biogen raises $40B in Public at $45B valuation. Biopharmaceutical company...

Editorial Team
Jan 1, 2024
0 min read•$40B
Biotech
Incyte

Incyte raises $25B Public at $28B valuation

Incyte raises $25B in Public at $28B valuation. Biopharmaceutical company...

Editorial Team
Jan 1, 2024
0 min read•$25B
Pharmaceutical
AbbVie

AbbVie raises $250B Public at $260B valuation

AbbVie raises $250B in Public at $260B valuation. Biopharmaceutical company...

Editorial Team
Jan 1, 2024
0 min read•$250B
Pharmaceuticals
AbbVie

AbbVie raises $300B Public at $320B valuation

AbbVie raises $300B in Public at $320B valuation. Biopharmaceutical company...

Editorial Team
Jan 1, 2024
0 min read•$300B
Pharmaceutical
Amgen

Amgen raises $140B Public at $150B valuation

Amgen raises $140B in Public at $150B valuation. Biopharmaceutical company...

Editorial Team
Jan 1, 2024
0 min read•$140B
Pagina 1

Visualizzazione di 9 report • Pagina 1 • Categoria: all

Rimani avanti rispetto al mercato

Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.